-
Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment
24 Apr 2024 07:54 GMT
… effects of a photosensitizer with paclitaxel and anti-PD-L1 combination … peptide triggers immunogenic pyroptosis for prostate cancer self-synergistic immunotherapy. Adv Funct …
-
Targeted Delivery of Geraniol via Hyaluronic Acid-Conjugation Enhances Its Anti-Tumor Activity Against Prostate Cancer
06 Jan 2024 06:50 GMT
… effective therapeutic agent for prostate cancer treatment. Its targeted … to CD44-positive prostate cancer cells.
Natural products … , Inc.
Cytotoxicity
Human prostate cancer cells, PC-3, … by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for …
-
Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms
22 Apr 2024 07:48 GMT
… , various small molecule drugs, including paclitaxel and gemcitabine, have been successfully … enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release …
-
The Landscape of Exosomes Biogenesis to Clinical Applications
22 Apr 2024 07:48 GMT
… therapeutic agents, such as doxorubicin, paclitaxel, or miRNAs, and to target … extracellular vesicles from urine for prostate cancer diagnosis. PLoS One. 2018;13 …
-
Intratumoral Treatment of Melanoma Tumors with Large Surface Area Microparticle Paclitaxel and Synergy with Immune Checkpoint Inhibition
22 Jan 2024 07:29 GMT
… peritoneal cancer,37,38 prostate cancer,9 and mucinous … administration of submicron particle paclitaxel to solid carcinomas induces … large surface area microparticle paclitaxel and docetaxel in … of intraperitoneal submicron particle paclitaxel (SPP) plus IV …
-
Ramucirumab by Eli Lilly and Co for Gallbladder Cancer: Likelihood of Approval
18 Apr 2024 03:41 GMT
… agent, or in combination with paclitaxel, is indicated for the treatment … refractory (castration-resistant, androgen-independent) prostate cancer, metastatic melanoma, bladder cancer, metastatic …
-
Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs
26 Jun 2023 07:46 GMT
… -resistance compared to paclitaxel and docetaxel.24 … T-cells in prostate tumors, and lower mutation … metastatic castration-resistant prostate cancers: a randomised, open … driven prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer …
-
Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers
15 Apr 2024 17:57 GMT
… by IDE196 (PKC inhibitor) or paclitaxel, demonstrating that the resistance mechanism … most impacted cell line, the prostate cancer cell line 22RV1, showed a … suggested that hematologic malignancies and prostate cancer cell lines are also very …
-
Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis
15 Apr 2024 07:25 GMT
… promoter in human lung and prostate cancer by methylation-specific PCR. BMC … (tgfbi) extracellular matrix deposition and paclitaxel response in ovarian cancer cells … and sensitizes ovarian cancers to paclitaxel. Cancer Cell. 2007;12(6 …
-
RenovoRx's Targeted Prostate Cancer Treatment Shows Positive Trend In Median Overall Survival Versus Standard Care
08 Mar 2023 16:51 GMT
RenovoRx Inc RNXT announced interim data in the Phase 3 open-label TIGeR-PaC clinical trial investigating the company's first product candidate, RenovoGem, as a potential treatment option in locally advanced pancreatic cancer (LAPC).
The interim …